Support Pathway for ENT Cancer Patients in a Support Care Day Hospital
ConditionOtorhinolaryngologic Neoplasms
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorClinique Pasteur Lanroze
About this trial
Cancers of the upper respiratory / digestive tract are a major public health problem, ranking 5th among the most common cancers. Surgery plays a central role in the recommended treatments for this type of pathology. The surgical procedure and its after-effects can be anxiety-provoking and have a major psychological, physical and social impact on patients over the long term.
Our institution's standard protocol is based on a pre-operative supportive care day hospital. The aim of this study is to compare our current care pathway with a more extensive interdisciplinary care pathway focused on patients' needs, in order to reduce anxiety and improve the quality of life of patients undergoing surgery for cancers of the upper respiratory / digestive tract.
Our aim is to use a prospective single-centre interventional study to assess the impact of adding three post-operative day hospitals to the existing care pathway in terms of reducing anxiety and improving the quality of life of patients undergoing surgery.
Eligibility criteria
Qualifiers
patient undergoing surgery for VADS cancer requiring at least one night's post-operative hospitalisation
Understanding of spoken and written French
Patient covered by a social security scheme
Disqualifiers
Protected patient under a protective measure or legal safeguard
Pregnant or breast-feeding patients
Patients suffering from major cognitive disorders
Patients with major anxiety disorders prior to the onset of cancer
Trial design
Treatments tested in this trial
- Consultations with paramedics
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov